Great Valley Advisor Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-575
| Closed | -$365K | – | 933 |
|
|
2025
Q1 | $365K | Buy |
575
+98
| +21% | +$62.2K | 0.01% | 667 |
|
|
2024
Q4 | $340K | Buy |
477
+35
| +8% | +$24.9K | 0.01% | 668 |
|
|
2024
Q3 | $465K | Buy |
442
+21
| +5% | +$22.1K | 0.01% | 580 |
|
|
2024
Q2 | $443K | Sell |
421
-233
| -36% | -$245K | 0.01% | 554 |
|
|
2024
Q1 | $629K | Buy |
654
+2
| +0.3% | +$1.93K | 0.02% | 446 |
|
|
2023
Q4 | $573K | Sell |
652
-502
| -44% | -$441K | 0.02% | 430 |
|
|
2023
Q3 | $950K | Buy |
1,154
+218
| +23% | +$179K | 0.04% | 322 |
|
|
2023
Q2 | $673K | Buy |
936
+172
| +23% | +$124K | 0.03% | 382 |
|
|
2023
Q1 | $628K | Buy |
+764
| New | +$628K | 0.03% | 394 |
|
|
2021
Q4 | – | Sell |
-543
| Closed | -$329K | – | 614 |
|
|
2021
Q3 | $329K | Buy |
+543
| New | +$329K | 0.02% | 444 |
|
|
2020
Q4 | – | Sell |
-417
| Closed | -$233K | – | 475 |
|
|
2020
Q3 | $233K | Buy |
417
+54
| +15% | +$30.2K | 0.03% | 378 |
|
|
2020
Q2 | $227K | Buy |
+363
| New | +$227K | 0.04% | 365 |
|